Startup

Nagi Bioscience

Description

Nagi Bioscience, a spin-off from EPFL, specializes in pioneering Organism-on-Chip technologies for automated high-content screening of substances, offering a 3R alternative to animal testing. Their cutting-edge laboratory equipment enables end-to-end screenings on micro-organisms, ensuring standardization and reproducibility. By integrating their technology, companies can identify adverse toxicology early in the R&D pipeline, reducing late-stage failures and costs. Nagi's innovative solutions, such as SydLab(tm) ONE, provide powerful methodologies for assessing lifespan and healthspan measures in model systems like C. elegans, offering a more ethical and efficient approach to biological testing.

Official source
About this result
This page is automatically generated and may contain information that is not correct, complete, up-to-date, or relevant to your search query. The same applies to every other page on this website. Please make sure to verify the information with EPFL's official sources.